https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-04 / Oncotarget 2016 Oct;7(40):65042-65051
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-04 / Oncotarget 2016 Oct;7(40):65042-650512016-10-04 00:00:002016-10-04 00:00:00Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-07-21 / Onco Targets Ther 2016;9:4441-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-07-21 / Onco Targets Ther 2016;9:4441-512016-07-21 00:00:002023-03-07 11:15:56Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-07-01 / Oncoimmunology 2017;6(9):e1207032
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-07-01 / Oncoimmunology 2017;6(9):e12070322016-07-01 00:00:002016-07-01 00:00:00Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER/HER2 early breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-17 / J Clin Oncol 36, 2018 (suppl; abstr e24000)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-17 / J Clin Oncol 36, 2018 (suppl; abstr e24000)2016-06-17 12:11:492019-07-17 12:12:15Anti-tumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr e12566)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr e12566)2016-06-05 12:12:422019-07-17 12:13:35Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1086)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1086)2016-06-05 12:10:572019-07-17 12:11:24Safety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1081)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1081)2016-06-05 12:10:062019-07-17 12:10:27Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-87
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-872015-12-21 00:00:002015-12-21 00:00:00Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-82015-11-02 00:00:002015-11-02 00:00:00Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-10-01 / Nat. Med. 2015 Oct;21(10):1128-38
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-10-01 / Nat. Med. 2015 Oct;21(10):1128-382015-10-01 00:00:002015-10-01 00:00:00Natural and therapy-induced immunosurveillance in breast cancer
